Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists

被引:67
作者
Kolibianakis, EM [1 ]
Zikopoulos, K [1 ]
Smitz, J [1 ]
Camus, M [1 ]
Tournaye, H [1 ]
Van Steirteghem, AC [1 ]
Devroey, P [1 ]
机构
[1] Dutch Speaking Brussels Free Univ, Ctr Reprod Med, B-1090 Brussels, Belgium
关键词
GnRH antagonists; IVF; ongoing pregnancy rate; progesterone elevation; recombinant FSH;
D O I
10.1093/humrep/deh272
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The objective of this prospective study was to assess the impact of elevated serum progesterone levels on day 2 of the cycle on pregnancy rates in patients treated by IVF using GnRH antagonists. METHODS: Ovarian stimulation was started on day 2 of the cycle if progesterone levels were normal (normal-P group, n = 390). In the presence of elevated progesterone, initiation of stimulation was postponed for 1 or 2 days (high-P group, n = 20) and was started if repeat progesterone levels returned to normal range (n = 16). Stimulation was performed with recombinant FSH (rFSH) and GnRH antagonist was always started on day 6 of stimulation. RESULTS: A significantly higher exposure to progesterone and a significantly lower exposure to estradiol was present in the high-P as compared with the normal-P group from day 1 to day 8 of stimulation. In addition, a significantly lower ongoing pregnancy rate both per started cycle (5.0% versus 31.8%; P = 0.01) and per embryo transfer (6.3% versus 36.9%; P = 0.01) was present in the high-P compared with the normal-P group, respectively. CONCLUSIONS: The presence of elevated serum progesterone on day 2 of the cycle is associated with a decreased chance of pregnancy in patients treated with rFSH and GnRH antagonists.
引用
收藏
页码:1525 / 1529
页数:5
相关论文
共 14 条
[1]   Ovarian stimulation with HMG:: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin [J].
Albano, C ;
Felberbaum, RE ;
Smitz, J ;
Riethmüller-Winzen, H ;
Engel, J ;
Diedrich, K ;
Devroey, P .
HUMAN REPRODUCTION, 2000, 15 (03) :526-531
[2]  
Borm G, 2000, HUM REPROD, V15, P1490
[3]   A RANDOMIZED, ASSESSOR-BLIND, GROUP-COMPARATIVE EFFICACY STUDY TO COMPARE THE EFFECTS OF NORMEGON(R) AND METRODIN(R) IN INFERTILE FEMALE-PATIENTS UNDERGOING IN-VITRO FERTILIZATION [J].
DEVROEY, P ;
TJANDRAPRAWIRA, K ;
MANNAERTS, B ;
BENNINK, HC ;
SMITZ, J ;
BONDUELLE, M ;
DEBRABANTER, A ;
VANSTEIRTEGHEM, AC .
HUMAN REPRODUCTION, 1995, 10 (02) :332-337
[4]   Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation [J].
Fluker, M ;
Grifo, J ;
Leader, A ;
Levy, M ;
Meldrum, D ;
Muasher, SJ ;
Rinehart, J ;
Rosenwaks, Z ;
Scott, RT ;
Schoolcraft, W ;
Shapiro, DB .
FERTILITY AND STERILITY, 2001, 75 (01) :38-45
[5]  
Gardner D.K., 1999, REPROD CERTAINTY INF, P377
[6]   The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer [J].
Huang, JC ;
Jackson, KV ;
Hornstein, MD ;
Ginsburg, ES .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1996, 13 (08) :617-624
[7]   Elevated serum progesterone concentrations during the early follicular phase of the menstrual cycle: clinical significance and therapeutic implications [J].
Keck, C ;
Neulen, J ;
Breig-Lauel, S ;
Breckwoldt, M .
GYNECOLOGICAL ENDOCRINOLOGY, 1999, 13 (03) :161-165
[8]   Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up [J].
Kolibianakis, E ;
Bourgain, C ;
Albano, C ;
Osmanagaoglu, K ;
Smitz, J ;
Van Steirteghem, A ;
Devroey, P .
FERTILITY AND STERILITY, 2002, 78 (05) :1025-1029
[9]   Luteolysis: A neuroendocrine-mediated event [J].
McCracken, JA ;
Custer, EE ;
Lamsa, JC .
PHYSIOLOGICAL REVIEWS, 1999, 79 (02) :263-323
[10]   Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin) [J].
Olivennes, F ;
Belaisch-Allart, J ;
Emperaire, JC ;
Dechaud, H ;
Alvarez, S ;
Moreau, L ;
Nicollet, B ;
Zorn, JR ;
Bouchard, P ;
Frydman, R .
FERTILITY AND STERILITY, 2000, 73 (02) :314-320